Andrew Babiskin

1.2k total citations
49 papers, 843 citations indexed

About

Andrew Babiskin is a scholar working on Pharmaceutical Science, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Andrew Babiskin has authored 49 papers receiving a total of 843 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pharmaceutical Science, 14 papers in Pulmonary and Respiratory Medicine and 10 papers in Molecular Biology. Recurrent topics in Andrew Babiskin's work include Inhalation and Respiratory Drug Delivery (14 papers), Drug Solubulity and Delivery Systems (11 papers) and Drug Transport and Resistance Mechanisms (7 papers). Andrew Babiskin is often cited by papers focused on Inhalation and Respiratory Drug Delivery (14 papers), Drug Solubulity and Delivery Systems (11 papers) and Drug Transport and Resistance Mechanisms (7 papers). Andrew Babiskin collaborates with scholars based in United States, United Kingdom and South Korea. Andrew Babiskin's co-authors include Christina D. Smolke, Liang Zhao, Xinyuan Zhang, Ross Walenga, Eleftheria Tsakalozou, Ming‐Liang Tan, Duxin Sun, Jamie N. Connarn, Lanyan Fang and Laleh Golshahi and has published in prestigious journals such as Nucleic Acids Research, Advanced Drug Delivery Reviews and Journal of Applied Physiology.

In The Last Decade

Andrew Babiskin

48 papers receiving 833 citations

Peers

Andrew Babiskin

PRM

PHARM

Ahmad Y. Abuhelwa Australia

Nikunjkumar Patel United Kingdom

Sivacharan Kollipara India

Alan Parr United States

Benjamin Weber United States

Donato Teutonico France

Xiaohui Jiang United States

Uwe Muenster Germany

Alyson Connor United Kingdom

Sam Haidar United States

Ahmad Y. Abuhelwa Australia

Andrew Babiskin

194 ×0.7

240 ×1.0

137 ×0.7

PRM

61 ×0.8

PHARM

15 ×0.2

Citations per year, relative to Andrew Babiskin Andrew Babiskin (= 1×) peers Ahmad Y. Abuhelwa

Countries citing papers authored by Andrew Babiskin

Since Specialization

Citations

This map shows the geographic impact of Andrew Babiskin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Babiskin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Babiskin more than expected).

Fields of papers citing papers by Andrew Babiskin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Babiskin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Babiskin. The network helps show where Andrew Babiskin may publish in the future.

Co-authorship network of co-authors of Andrew Babiskin

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Babiskin. A scholar is included among the top collaborators of Andrew Babiskin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Babiskin. Andrew Babiskin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Walenga, Ross, Andrew Babiskin, Xin Feng, et al.. (2025). Nasal absorption of oxycodone predicted using a novel computational fluid dynamics-physiologically based pharmacokinetic model. Journal of Controlled Release. 378. 982–996.

Cheng, Yi‐Hsien, Muhammad Aqeel Ashraf, Tycho Heimbach, et al.. (2025). Advances in Physiologically Based Pharmacokinetic (PBPK) Modeling and its Regulatory Utility to Support Oral Drug Product Development and Harmonization. Pharmaceutical Research. 42(5). 819–833. 4 indexed citations

Walenga, Ross, Andrew Babiskin, James F. Clarke, et al.. (2024). Use of the Same Model or Modeling Strategy Across Multiple Submissions: Focus on Complex Drug Products. The AAPS Journal. 26(1). 12–12. 1 indexed citations

Kimbell, Julia S., Guilherme J. M. Garcia, Poonam Sheth, et al.. (2023). Nasal steroid spray simulations using measured spray characteristics in healthy and rhinitic nasal passages. Journal of Aerosol Science. 174. 106246–106246. 5 indexed citations

Tan, Ming‐Liang, Zongming Gao, Andrew Babiskin, et al.. (2023). Use of physiologically‐based pharmacokinetic modeling to understand the effect of omeprazole administration on the pharmacokinetics of oral extended‐release nifedipine. CPT Pharmacometrics & Systems Pharmacology. 13(2). 247–256. 3 indexed citations

Yoon, Miyoung, Andrew Babiskin, Meng Hu, et al.. (2023). Increasing impact of quantitative methods and modeling in establishment of bioequivalence and characterization of drug delivery. CPT Pharmacometrics & Systems Pharmacology. 12(5). 552–555. 7 indexed citations

Babiskin, Andrew, Fang Wu, Ming‐Liang Tan, et al.. (2023). Regulatory utility of mechanistic modeling to support alternative bioequivalence approaches: A workshop overview. CPT Pharmacometrics & Systems Pharmacology. 12(5). 619–623. 10 indexed citations

German, Carrie, Zhijian J. Chen, Andrzej Przekwas, et al.. (2023). Computational Model of In Vivo Corneal Pharmacokinetics and Pharmacodynamics of Topically Administered Ophthalmic Drug Products. Pharmaceutical Research. 40(4). 961–975. 4 indexed citations

Kolanjiyil, Arun V., Ross Walenga, Andrew Babiskin, et al.. (2023). Establishing quantitative relationships between changes in nasal spray in vitro metrics and drug delivery to the posterior nasal region. International Journal of Pharmaceutics. 635. 122718–122718. 5 indexed citations

10.

Choi, Jiwoong, et al.. (2023). Transport and deposition of beclomethasone dipropionate drug aerosols with varying ethanol concentration in severe asthmatic subjects. International Journal of Pharmaceutics. 636. 122805–122805. 5 indexed citations

11.

Singh, Narender, et al.. (2021). A quasi-3D model of the whole lung: airway extension to the tracheobronchial limit using the constrained constructive optimization and alveolar modeling, using a sac–trumpet model. Journal of Computational Design and Engineering. 8(2). 691–704. 3 indexed citations

12.

Tan, Ming‐Liang, et al.. (2020). Physiologically Based Pharmacokinetic Model to Support Ophthalmic Suspension Product Development. The AAPS Journal. 22(2). 26–26. 25 indexed citations

13.

Manniello, Michele Dario, Sana Hosseini, Amir R. Esmaeili, et al.. (2020). In vitro evaluation of regional nasal drug delivery using multiple anatomical nasal replicas of adult human subjects and two nasal sprays. International Journal of Pharmaceutics. 593. 120103–120103. 27 indexed citations

14.

Pépin, Xavier, Neil Parrott, Jennifer Dressman, et al.. (2020). Current State and Future Expectations of Translational Modeling Strategies to Support Drug Product Development, Manufacturing Changes and Controls: A Workshop Summary Report. Journal of Pharmaceutical Sciences. 110(2). 555–566. 41 indexed citations

15.

Lukáčová, Viera, Ming‐Liang Tan, Andrew Babiskin, et al.. (2020). Ocular Physiologically Based Pharmacokinetic Modeling for Ointment Formulations. Pharmaceutical Research. 37(12). 245–245. 16 indexed citations

16.

Pépin, Xavier, Jennifer Dressman, Neil Parrott, et al.. (2020). In Vitro Biopredictive Methods: A Workshop Summary Report. Journal of Pharmaceutical Sciences. 110(2). 567–583. 17 indexed citations

17.

Choi, Jiwoong, Lawrence J. LeBlanc, Sanghun Choi, et al.. (2019). Differences in Particle Deposition Between Members of Imaging-Based Asthma Clusters. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 32(4). 213–223. 24 indexed citations

18.

Walenga, Ross, et al.. (2018). Impact of Vehicle Physicochemical Properties on Modeling-Based Predictions of Cyclosporine Ophthalmic Emulsion Bioavailability and Tear Film Breakup Time. Journal of Pharmaceutical Sciences. 108(1). 620–629. 19 indexed citations

19.

Hu, Meng, et al.. (2018). What Factors May Impact the Likelihood of First Abbreviated New Drug Application (ANDA) Submission for a Reference Product?. Value in Health. 21. S116–S116. 2 indexed citations

20.

Connarn, Jamie N., Stephanie A. Flowers, Marisa Kelly, et al.. (2017). Pharmacokinetics and Pharmacogenomics of Bupropion in Three Different Formulations with Different Release Kinetics in Healthy Human Volunteers. The AAPS Journal. 19(5). 1513–1522. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact